Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02413853
Title Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications

colorectal adenocarcinoma

Therapies

Bevacizumab

PRI-724

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.